NCT02161731View on ClinicalTrials.gov

Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

Oral administration

DRUG

Warfarin

Oral administration

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02161731 - Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants | Biotech Hunter | Biotech Hunter